These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34935425)

  • 1. Procedural Risk in Congenital Cardiac Catheterization (PREDIC
    Quinn BP; Yeh M; Gauvreau K; Ali F; Balzer D; Barry O; Batlivala S; Berman D; Foerster S; Goldstein B; Hainstock M; Holzer R; Janssen D; O'Byrne ML; Shirley L; Trucco S; Whiteside W; Bergersen L
    J Am Heart Assoc; 2022 Jan; 11(1):e022832. PubMed ID: 34935425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling Major Adverse Outcomes of Pediatric and Adult Patients With Congenital Heart Disease Undergoing Cardiac Catheterization: Observations From the NCDR IMPACT Registry (National Cardiovascular Data Registry Improving Pediatric and Adult Congenital Treatment).
    Jayaram N; Spertus JA; Kennedy KF; Vincent R; Martin GR; Curtis JP; Nykanen D; Moore PM; Bergersen L
    Circulation; 2017 Nov; 136(21):2009-2019. PubMed ID: 28882885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catheterization for Congenital Heart Disease Adjustment for Risk Method (CHARM).
    Bergersen L; Gauvreau K; Foerster SR; Marshall AC; McElhinney DB; Beekman RH; Hirsch R; Kreutzer J; Balzer D; Vincent J; Hellenbrand WE; Holzer R; Cheatham JP; Moore JW; Burch G; Armsby L; Lock JE; Jenkins KJ
    JACC Cardiovasc Interv; 2011 Sep; 4(9):1037-46. PubMed ID: 21939947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of PREDIC
    Kobayashi D; Amin EK; Morgan GJ; Reddy SRV; Fleming GA; Forbes TJ; Nykanen DG
    Am J Cardiol; 2024 Feb; 212():73-79. PubMed ID: 38040279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catheterization for Congenital Heart Disease Adjustment for Risk Method II.
    Quinn BP; Gunnelson LC; Kotin SG; Gauvreau K; Yeh MJ; Hasan B; Lozier J; Barry OM; Shahanavaz S; Batlivala SP; Salavitabar A; Foerster S; Goldstein B; Divekar A; Holzer R; Nicholson GT; O'Byrne ML; Whiteside W; Bergersen L
    Circ Cardiovasc Interv; 2024 Mar; 17(3):e012834. PubMed ID: 38258562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between procedural adverse events associated with cardiac catheterization for congenital heart disease and operator factors: results of a multi-institutional registry (C3PO).
    Holzer RJ; Gauvreau K; Kreutzer J; Moore JW; McElhinney DB; Bergersen L
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):463-73. PubMed ID: 23413194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and management of life-threatening adverse events during cardiac catheterization for congenital heart disease.
    Lin CH; Hegde S; Marshall AC; Porras D; Gauvreau K; Balzer DT; Beekman RH; Torres A; Vincent JA; Moore JW; Holzer R; Armsby L; Bergersen L
    Pediatr Cardiol; 2014 Jan; 35(1):140-8. PubMed ID: 23900744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practice Variation in Single-Ventricle Patients Undergoing Elective Cardiac Catheterization: A Report from the Congenital Cardiac Catheterization Project on Outcomes (C3PO).
    Goldstein BH; Holzer RJ; Trucco SM; Porras D; Murphy J; Foerster SR; El-Said HG; Beekman RH; Bergersen L
    Congenit Heart Dis; 2016; 11(2):122-35. PubMed ID: 26356648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse events rates and risk factors in adults undergoing cardiac catheterization at pediatric hospitals--results from the C3PO.
    Learn CP; Holzer RJ; Daniels CJ; Torres AJ; Vincent JA; Moore JW; Armsby LB; Landzberg MJ; Bergersen L
    Catheter Cardiovasc Interv; 2013 May; 81(6):997-1005. PubMed ID: 23345073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A risk adjusted method for comparing adverse outcomes among practitioners in pediatric and congenital cardiac catheterization.
    Bergersen L; Gauvreau K; Lock JE; Jenkins KJ
    Congenit Heart Dis; 2008; 3(4):230-40. PubMed ID: 18715456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse event rates in congenital cardiac catheterization: a new understanding of risks.
    Bergersen L; Gauvreau K; Jenkins KJ; Lock JE
    Congenit Heart Dis; 2008; 3(2):90-105. PubMed ID: 18380758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing tools to measure quality in congenital catheterization and interventions: the congenital cardiac catheterization project on outcomes (C3PO).
    Chaudhry-Waterman N; Coombs S; Porras D; Holzer R; Bergersen L
    Methodist Debakey Cardiovasc J; 2014; 10(2):63-7. PubMed ID: 25114756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Postoperative Congenital Cardiac Catheterization Outcomes: A Multicenter Study.
    Yeh MJ; Gauvreau K; Armstrong AK; Batlivala SP; Callahan R; Gudausky TM; Hainstock MR; Hasan B; Nicholson GT; O'Byrne ML; Shahanavaz S; Trucco S; Zampi JD; Bergersen L
    Ann Thorac Surg; 2023 Jul; 116(1):86-93. PubMed ID: 36481325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjusting for Risk Associated With Pediatric and Congenital Cardiac Catheterization: A Report From the NCDR IMPACT Registry.
    Jayaram N; Beekman RH; Benson L; Holzer R; Jenkins K; Kennedy KF; Martin GR; Moore JW; Ringel R; Rome J; Spertus JA; Vincent R; Bergersen L
    Circulation; 2015 Nov; 132(20):1863-70. PubMed ID: 26481778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Improvements in Radiation Exposure in Cardiac Catheterization for Congenital Heart Disease: A Prospective Multicenter C3PO-QI Study.
    Quinn BP; Cevallos P; Armstrong A; Balzer D; El-Said H; Foerster S; Glatz AC; Goodman A; Goldstein B; Hainstock M; Janssen D; Kreutzer J; Latson L; Leahy R; Petit C; Shahanavaz S; Trucco S; Whiteside W; Zampi JD; Bergersen L
    Circ Cardiovasc Interv; 2020 May; 13(5):e008172. PubMed ID: 32408819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and safety of interventions and procedures performed during catheterisation of patients with congenital heart disease: early report from the national cardiovascular data registry.
    Holzer R; Beekman R; Benson L; Bergersen L; Jayaram N; Jenkins K; Kennedy K; Moore J; Ringel R; Rome J; Vincent R; Martin GR
    Cardiol Young; 2016 Aug; 26(6):1202-12. PubMed ID: 26455737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low weight as an independent risk factor for adverse events during cardiac catheterization of infants.
    Backes CH; Cua C; Kreutzer J; Armsby L; El-Said H; Moore JW; Gauvreau K; Bergersen L; Holzer RJ
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):786-94. PubMed ID: 23436647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation Risk Categories in Cardiac Catheterization for Congenital Heart Disease: A Tool to Aid in the Evaluation of Radiation Outcomes.
    Quinn BP; Armstrong AK; Bauser-Heaton HD; Callahan R; El-Said HG; Foerster SR; Goldstein BH; Goodman AS; Gudausky TM; Kreutzer JN; Leahy RA; Petit CJ; Rockefeller TA; Shahanavaz S; Trucco SM; Bergersen L;
    Pediatr Cardiol; 2019 Feb; 40(2):445-453. PubMed ID: 30506273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation and refinement of the catheterization RISk score for pediatrics (CRISP score): An analysis from the congenital cardiac interventional study consortium.
    Hill KD; Du W; Fleming GA; Forbes TJ; Nykanen DG; Reeves J; Du Y; Kobayashi D
    Catheter Cardiovasc Interv; 2019 Jan; 93(1):97-104. PubMed ID: 30196566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation dose benchmarks in pediatric cardiac catheterization: A prospective multi-center C3PO-QI study.
    Cevallos PC; Armstrong AK; Glatz AC; Goldstein BH; Gudausky TM; Leahy RA; Petit CJ; Shahanavaz S; Trucco SM; Bergersen LJ
    Catheter Cardiovasc Interv; 2017 Aug; 90(2):269-280. PubMed ID: 28198573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.